🔗 Permalink

Inventor profile of:

Joerg Thomas Regula

City:

Muenchen

Country:

Germany

Published Applications:

Last publication date:

2026-01-22

Top Assignees for applications by Joerg Thomas Regula

The entities that hold a legal rights for patent applications filed by inventor Regula Joerg Thomas:

HOFFMANN-LA ROCHE INC. 45 Little Falls, NJ United States
Hoffmann-La Roche Inc. 16 Nutley, NJ United States
ROCHE GLYCART AG 3 Schlieren, Switzerland
Hoffman-La Roche. Inc. 2 Nutley, NJ United States
Hoffman-La Roche Inc. 2 Little Falls, NJ United States
Roche GlycArt AG 1 , Switzerland
Hoffmann-La Roche Inc. 1 Little Falls, Switzerland
Roche Palo Alto LLC 1 Palo Alto, CA United States
F. Hoffmann-La Roche AG 1 Basel, Switzerland
Hofmann-La Roche Inc. 1 Little Falls, NJ United States

Recent patent applications by Regula Joerg Thomas

Joerg Thomas Regula from Muenchen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-22

US20260022172A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#2 | 2024-09-26

US20240317879A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#3 | 2024-05-02

US20240141044A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#4 | 2024-03-07

US20240077495A1

Physics

SPR-BASED BRIDGING ASSAY FORMAT FOR DETERMINING THE BIOLOGICAL ACTIVITY OF MULTIVALENT, MULTISPECIFIC MOLECULES

#5 | 2023-12-14

US20230399391A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#6 | 2023-09-14

US20230287118A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#7 | 2023-07-06

US20230212277A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR VASCULAR DISEASES

#8 | 2023-03-02

US20230068801A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#9 | 2022-12-22

US20220403027A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#10 | 2022-10-13

US20220324955A1

Chemistry; metallurgy

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

#11 | 2022-09-29

US20220306761A1

Chemistry; metallurgy

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

#12 | 2022-08-18

US20220259327A1

Chemistry; metallurgy

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER

#13 | 2022-08-18

US20220259326A1

Chemistry; metallurgy

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER

#14 | 2021-12-16

US20210388071A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#15 | 2021-10-07

US20210309730A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#16 | 2021-07-01

US20210199666A1

Physics

SPR-BASED BRIDGING ASSAY FORMAT FOR DETERMINING THE BIOLOGICAL ACTIVITY OF MULTIVALENT, MULTISPECIFIC MOLECULES

#17 | 2021-07-01

US20210198383A1

Chemistry; metallurgy

Method for determining the in vivo interaction mode

#18 | 2021-04-01

US20210095013A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR VASCULAR DISEASES

#19 | 2021-02-18

US20210047394A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#20 | 2020-11-26

US20200369758A1

Chemistry; metallurgy

Bispecific antigen binding proteins

#21 | 2020-08-20

US20200262904A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#22 | 2020-08-06

US20200247904A1

Chemistry; metallurgy

Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer

#23 | 2020-07-23

US20200231673A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#24 | 2020-06-04

US20200172607A1

Chemistry; metallurgy

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

#25 | 2020-03-26

US20200095310A1

Chemistry; metallurgy

Fc-receptor binding modified asymmetric antibodies and methods of use

#26 | 2019-12-19

US20190382507A1

Chemistry; metallurgy

Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer

#27 | 2019-01-17

US20190016827A1

Chemistry; metallurgy

METHOD FOR DETERMINING THE IN VIVO INTERACTION MODE

#28 | 2018-11-01

US20180312573A1

Chemistry; metallurgy

Nucleic acid encoding dual Fc antigen binding proteins

#29 | 2018-10-04

US20180282404A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#30 | 2018-08-09

US20180222981A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#31 | 2018-08-09

US20180222980A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#32 | 2018-06-14

US20180164325A1

Physics

IMMUNOGLOBULIN GLYCOSYLATION PATTERN ANALYSIS

#33 | 2018-03-22

US20180079805A1

Chemistry; metallurgy

Bispecific antigen binding proteins

#34 | 2018-02-08

US20180037633A1

Chemistry; metallurgy

Monovalent antigen binding proteins

#35 | 2017-12-28

US20170369566A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#36 | 2017-12-07

US20170349669A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#37 | 2017-09-14

US20170260265A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

#38 | 2017-08-31

US20170247441A1

Chemistry; metallurgy

Anti-ANG2 antibodies and methods of use

#39 | 2017-08-31

US20170247440A1

Chemistry; metallurgy

Anti-PDGF-B antibodies and methods of use

#40 | 2017-08-24

US20170240629A1

Chemistry; metallurgy

Bispecific antibodies and methods of use in ophthalmology

#41 | 2017-08-24

US20170240626A1

Chemistry; metallurgy

BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#42 | 2017-02-02

US20170029493A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#43 | 2017-01-05

US20170003295A1

Physics

SPR-BASED BRIDGING ASSAY FORMAT FOR DETERMINING THE BIOLOGICAL ACTIVITY OF MULTIVALENT, MULTISPECIFIC MOLECULES

#44 | 2016-07-14

US20160200833A1

Chemistry; metallurgy

Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules

#45 | 2016-07-07

US20160194389A1

Chemistry; metallurgy

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

#46 | 2016-06-09

US20160159894A1

Chemistry; metallurgy

Human FcRn-binding modified antibodies and methods of use

#47 | 2016-06-02

US20160151487A1

Human necessities

FCRN-BINDING ABOLISHED ANTI-IGF-1R ANTIBODIES AND THEIR USE IN THE TREATMENT OF VASCULAR EYE DISEASES

#48 | 2016-03-17

US20160075785A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#49 | 2016-03-10

US20160068613A1

Chemistry; metallurgy

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

#50 | 2015-11-05

US20150315296A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#51 | 2015-10-08

US20150284457A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#52 | 2015-07-09

US20150191535A1

Chemistry; metallurgy

BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG2 ANTIBODIES

#53 | 2015-04-09

US20150099699A1

Human necessities

Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)

#54 | 2015-02-12

US20150044214A1

Chemistry; metallurgy

BISPECIFIC, TETRAVALENT ANTIGEN BINDING PROTEINS

#55 | 2015-01-01

US20150004166A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#56 | 2014-03-06

US20140065707A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#57 | 2014-03-06

US20140065151A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#58 | 2014-01-16

US20140017244A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

#59 | 2013-08-22

US20130217623A1

Human necessities

CONJUGATES OF INSULIN-LIKE GROWTH FACTOR-1 AND POLY(ETHYLENE GLYCOL)

#60 | 2013-06-20

US20130156789A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#61 | 2013-03-14

US20130065831A1

Chemistry; metallurgy

Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)

#62 | 2012-12-20

US20120321627A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#63 | 2012-09-20

US20120237507A1

Chemistry; metallurgy

Monovalent Antigen Binding Proteins

#64 | 2012-09-20

US20120237506A1

Chemistry; metallurgy

Dual FC antigen binding proteins

#65 | 2012-06-07

US20120142091A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#66 | 2012-06-07

US20120141500A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#67 | 2011-12-01

US20110294150A1

Physics

IMMUNOGLOBULIN GLYCOSYLATION PATTERN ANALYSIS

#68 | 2011-09-29

US20110236388A1

Chemistry; metallurgy

Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies

#69 | 2011-07-28

US20110183354A1

Chemistry; metallurgy

HUMAN Fc GAMMA RECEPTOR III

#70 | 2011-04-14

US20110086026A1

Chemistry; metallurgy

ANTIBODIES AGAINST IL-13 RECEPTOR ALPHA 1 AND USES THEREOF

#71 | 2010-12-23

US20100322934A1

Chemistry; metallurgy

Bispecific, tetravalent antigen binding proteins

#72 | 2010-12-16

US20100316645A1

Chemistry; metallurgy

Bispecific antigen binding proteins

#73 | 2010-10-07

US20100256338A1

Chemistry; metallurgy

Multispecific antibodies comprising full length antibodies and single chain fab fragments

#74 | 2010-08-19

US20100210547A1

Chemistry; metallurgy

METHOD FOR THE PRODUCTION OF CONJUGATES OF INSULIN-LIKE GROWTH FACTOR-1 AND POLY(ETHYLENE GLYCOL)

#75 | 2010-06-24

US20100159587A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#76 | 2010-05-13

US20100121036A1

Chemistry; metallurgy

Method for the production of insulin-like growth factor-1

#77 | 2010-05-06

US20100111967A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#78 | 2010-02-11

US20100035817A1

Chemistry; metallurgy

METHOD FOR THE PRODUCTION OF CONJUGATES OF INSULIN-LIKE GROWTH FACTOR-1 AND POLY(ETHYLENE GLYCOL)

#79 | 2008-10-09

US20080248510A1

Chemistry; metallurgy

HUMAN Fc GAMMA RECEPTOR III

#80 | 2008-05-22

US20080119409A1

Chemistry; metallurgy

Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)

#81 | 2006-11-23

US20060263356A1

Chemistry; metallurgy

Antibodies against IL-13 receptor alpha1 and uses thereof

InventorID:

140815 ⎘